QVT
VRTX icon

Quantitative Value Technologies’s Vertex Pharmaceuticals VRTX Stock Holding History

Quantitative Value Technologies’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$333K Buy
1,652
+4
+0.2% +$837 0.55% 88
2021
Q1 		$354K Buy
+1,648
New +$362K 0.76% 69

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Quantitative Value Technologies's VRTX Position: Q2 2021 in Review

Quantitative Value Technologies increased its Vertex Pharmaceuticals (VRTX) stake by 0.24% in Q2 2021, buying an estimated $837 and bringing the position to 1,652 shares worth $333K. The position accounts for 0.55% of the portfolio, ranked #88.

Quantitative Value Technologies first reported a position in VRTX in Q1 2021 and has held it in 2 quarters since. The position peaked at $354K in Q1 2021. 976 funds tracked by Wall St. Rank hold VRTX as of Q2 2021.

  • Quantitative Value Technologies held 1,652 shares of Vertex Pharmaceuticals worth $333K as of Q2 2021.
  • Quantitative Value Technologies bought 4 Vertex Pharmaceuticals shares in Q2 2021, an estimated $837.
  • Vertex Pharmaceuticals made up 0.55% of Quantitative Value Technologies's portfolio in Q2 2021, its #88 holding.
  • Quantitative Value Technologies first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 2 quarters since.
  • Quantitative Value Technologies's Vertex Pharmaceuticals position peaked at $354K in Q1 2021.
  • 976 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2021.

Based on Quantitative Value Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.